Why is Shukra Pharma. falling/rising?

As of 07-Jul, Shukra Pharmaceuticals Ltd is experiencing a rise in its stock price, currently at 18.28, with an increase of 0.87 or 5.0%. The stock has shown strong performance recently, gaining 36.42% over the last seven days and outperforming its sector by 5.08% today. Additionally, it has generated impressive returns over various periods, including an 81.26% increase over the past year, significantly higher than the market's return of 1.74%. However, despite these positive indicators, the company has reported a decline in net sales and profits, with net sales dropping by 45.95% and profits falling by 49.83% over the last nine months. This juxtaposition of strong stock performance against declining financial results may create a complex outlook for investors.
In the broader market context, Shukra Pharmaceuticals has outperformed the benchmark Sensex, which has seen a slight decline of 0.20% over the past week while the stock surged by 27.48%. This stark contrast highlights the stock's strong market-beating performance, particularly in light of its low Debt to EBITDA ratio and healthy long-term growth in operating profit. However, the lack of domestic mutual fund investment, which stands at 0%, may indicate caution among institutional investors regarding the stock's valuation, as it trades at a premium compared to its peers. Overall, while the stock is rising, the underlying financial challenges and investor sentiment may pose risks moving forward.